Cargando…

Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis

BACKGROUND: Inflammation in the peritumoral normal tissues has impact on tumors. This study investigated the prognostic impact of portal area inflammation (PAI) on postoperative tumor recurrence and overall survival (OS) in patients undergoing resection for intrahepatic cholangiocarcinoma (ICC) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaochen, Chen, Wuyu, Tao, Rongsuo, Yuan, Jianyong, Ruan, Minghao, Du, Jin, Guo, Xinggang, Liu, Fuchen, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643580/
https://www.ncbi.nlm.nih.gov/pubmed/37969826
http://dx.doi.org/10.21037/jgo-22-1143
_version_ 1785147132457517056
author Feng, Xiaochen
Chen, Wuyu
Tao, Rongsuo
Yuan, Jianyong
Ruan, Minghao
Du, Jin
Guo, Xinggang
Liu, Fuchen
Liu, Hui
author_facet Feng, Xiaochen
Chen, Wuyu
Tao, Rongsuo
Yuan, Jianyong
Ruan, Minghao
Du, Jin
Guo, Xinggang
Liu, Fuchen
Liu, Hui
author_sort Feng, Xiaochen
collection PubMed
description BACKGROUND: Inflammation in the peritumoral normal tissues has impact on tumors. This study investigated the prognostic impact of portal area inflammation (PAI) on postoperative tumor recurrence and overall survival (OS) in patients undergoing resection for intrahepatic cholangiocarcinoma (ICC) without lymph node metastasis (LNM). METHODS: Two hundred and ninety-seven patients who had undergone curative-intent resection at the Eastern Hepatobiliary Surgery Hospital, Shanghai, between 2011 and 2015 were selected. All patients were histologically diagnosed with ICC and had no LNM. PAI was defined by experienced pathologists based on standard pathological evaluations. Patients were divided into two groups according to the presence or absence of PAI. Further survival analysis was performed on PAI-related endpoints, OS, and recurrence-free survival (RFS), using Kaplan-Meier analysis and multivariate regression. RESULTS: Among the 297 patients included in the study, the PAI incidence was 43.1% (128 patients). OS and RFS were worse in patients with PAI than in those without PAI (median OS, 21.87 months with PAI versus 33.37 months without PAI, P<0.001; median RFS, 12.33 months with PAI versus 21.60 months without PAI, P<0.001). Multivariate analysis revealed that PAI was an independent prognostic factor for both OS [hazard ratio (HR) 1.60; 95% confidence interval (CI): 1.18–2.17, P=0.003] and RFS (HR 1.40; 95% CI: 1.06–1.85, P=0.019). CONCLUSIONS: Consequently, PAI is a strong independent predictor of tumor recurrence and OS after curative-intent resection in patients with ICC without LNM. The impact of PAI on the postoperative prognosis of ICC patients without LNM is non-negligible. It is strongly recommended to pay attention to the inflammatory status of the portal area in ICC patients and increase the frequency of postoperative follow-up to improve the prognosis of ICC patients after curative resection.
format Online
Article
Text
id pubmed-10643580
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-106435802023-11-15 Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis Feng, Xiaochen Chen, Wuyu Tao, Rongsuo Yuan, Jianyong Ruan, Minghao Du, Jin Guo, Xinggang Liu, Fuchen Liu, Hui J Gastrointest Oncol Original Article BACKGROUND: Inflammation in the peritumoral normal tissues has impact on tumors. This study investigated the prognostic impact of portal area inflammation (PAI) on postoperative tumor recurrence and overall survival (OS) in patients undergoing resection for intrahepatic cholangiocarcinoma (ICC) without lymph node metastasis (LNM). METHODS: Two hundred and ninety-seven patients who had undergone curative-intent resection at the Eastern Hepatobiliary Surgery Hospital, Shanghai, between 2011 and 2015 were selected. All patients were histologically diagnosed with ICC and had no LNM. PAI was defined by experienced pathologists based on standard pathological evaluations. Patients were divided into two groups according to the presence or absence of PAI. Further survival analysis was performed on PAI-related endpoints, OS, and recurrence-free survival (RFS), using Kaplan-Meier analysis and multivariate regression. RESULTS: Among the 297 patients included in the study, the PAI incidence was 43.1% (128 patients). OS and RFS were worse in patients with PAI than in those without PAI (median OS, 21.87 months with PAI versus 33.37 months without PAI, P<0.001; median RFS, 12.33 months with PAI versus 21.60 months without PAI, P<0.001). Multivariate analysis revealed that PAI was an independent prognostic factor for both OS [hazard ratio (HR) 1.60; 95% confidence interval (CI): 1.18–2.17, P=0.003] and RFS (HR 1.40; 95% CI: 1.06–1.85, P=0.019). CONCLUSIONS: Consequently, PAI is a strong independent predictor of tumor recurrence and OS after curative-intent resection in patients with ICC without LNM. The impact of PAI on the postoperative prognosis of ICC patients without LNM is non-negligible. It is strongly recommended to pay attention to the inflammatory status of the portal area in ICC patients and increase the frequency of postoperative follow-up to improve the prognosis of ICC patients after curative resection. AME Publishing Company 2023-10-07 2023-10-31 /pmc/articles/PMC10643580/ /pubmed/37969826 http://dx.doi.org/10.21037/jgo-22-1143 Text en 2023 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Feng, Xiaochen
Chen, Wuyu
Tao, Rongsuo
Yuan, Jianyong
Ruan, Minghao
Du, Jin
Guo, Xinggang
Liu, Fuchen
Liu, Hui
Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
title Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
title_full Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
title_fullStr Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
title_full_unstemmed Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
title_short Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
title_sort prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643580/
https://www.ncbi.nlm.nih.gov/pubmed/37969826
http://dx.doi.org/10.21037/jgo-22-1143
work_keys_str_mv AT fengxiaochen prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT chenwuyu prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT taorongsuo prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT yuanjianyong prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT ruanminghao prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT dujin prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT guoxinggang prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT liufuchen prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis
AT liuhui prognosticimpactofportalareainflammationonintrahepaticcholangiocarcinomapatientswithoutlymphnodemetastasis